Quick10K

⚲

Cyanotech

Filings

10-Q	2020-12-31	Filed 2021-02-11
10-Q	2020-09-30	Filed 2020-11-12
10-Q	2020-06-30	Filed 2020-08-11
10-K	2020-03-31	Filed 2020-06-23
10-Q	2019-12-31	Filed 2020-02-11
10-Q	2019-09-30	Filed 2019-11-12
10-Q	2019-06-30	Filed 2019-08-13
10-K	2019-03-31	Filed 2019-07-01
10-Q	2018-12-31	Filed 2019-02-13
10-Q	2018-09-30	Filed 2018-11-13
10-Q	2018-06-30	Filed 2018-08-13
10-K	2018-03-31	Filed 2018-06-15
10-Q	2017-12-31	Filed 2018-02-06
10-Q	2017-09-30	Filed 2017-11-06
10-Q	2017-06-30	Filed 2017-08-10
10-K	2017-03-31	Filed 2017-06-22
10-Q	2016-12-31	Filed 2017-02-07
10-Q	2016-09-30	Filed 2016-11-10
10-Q	2016-06-30	Filed 2016-08-15
10-K	2016-03-31	Filed 2016-06-23
10-Q	2015-12-31	Filed 2016-02-11
10-Q	2015-09-30	Filed 2015-11-12
10-Q	2015-06-30	Filed 2015-08-07
10-K	2015-03-31	Filed 2015-07-15
10-Q	2014-12-31	Filed 2015-02-12
10-Q	2014-09-30	Filed 2014-11-12
10-Q	2014-06-30	Filed 2014-08-14
10-K	2014-03-31	Filed 2014-06-27
10-Q	2013-12-31	Filed 2014-02-06
10-Q	2013-09-30	Filed 2013-11-07
10-Q	2013-06-30	Filed 2013-08-12
10-K	2013-03-31	Filed 2013-06-24
10-Q	2012-12-31	Filed 2013-02-07
10-Q	2012-09-30	Filed 2012-11-09
10-Q	2012-06-30	Filed 2012-08-10
10-K	2012-03-31	Filed 2012-06-21
10-Q	2011-12-31	Filed 2012-02-09
10-Q	2011-09-30	Filed 2011-11-14
10-Q	2011-06-30	Filed 2011-08-11
10-K	2011-03-31	Filed 2011-06-23
10-Q	2010-12-31	Filed 2011-02-11
10-Q	2010-09-30	Filed 2010-11-10
10-Q	2010-06-30	Filed 2010-08-12
10-K	2010-03-31	Filed 2010-06-24
10-Q	2009-12-31	Filed 2010-02-11

Reports

8-K	2020-09-25
8-K	2020-08-27
8-K	2020-05-05
8-K	2019-08-22
8-K	2019-06-03
8-K	2019-04-26
8-K	2019-04-12
8-K	2019-01-03
8-K	2018-11-30
8-K	2018-11-06
8-K	2018-08-31
8-K	2018-08-27
8-K	2018-04-13
8-K	2018-01-24

Cyanotech Financials

CYAN Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
ENETI INC. (NETI)
024 Pharma (EEIG)
Vivus (VVUS)	41	77%	-17.5	-11%	226	289	73	56	-25	-14	243
Clovis Oncology (CLVS)	219	0%	-0.0	-56%	717	804	134	0	-400	-394	18
Cementos Pacasmayo Saa (CPAC)	4,145			0%	2,863	1,412	0	0	0	0	4,145
11 Good Energy (ELVN)
Exantas Capital (XAN)
1347 Capital Corp (TFSC)
Bancorp of New Jersey (BKJ)	123		1.0	0%	962	869	0	0	3	15	14
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
30DC (TDCH)
3D Pioneer Systems (DPSM)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	3	4	4	5	5	4	4	4	3	3	3	4	3	3	3	2	2	2	2	1	2	2	2	1	1	2	2	1	1	1	2	1	1	1
Accounts Receivable	3	3	3	2	3	4	4	4	4	4	5	3	3	4	4	3	4	4	3	3	2	3	2	2	3	2	3	3	3	2	2	2	2	2
Inventory	3	3	4	4	3	3	3	4	4	4	5	5	5	5	7	6	6	6	7	8	8	7	8	8	8	9	10	9	9	10	10	11	12	11
PP&E			5	6	6	7	8	9	10	11	11	12	12	13	20	15	21	22	29	31	32	32	32	32	32	32	32	33	33	33	33	34	34	34
Assets	14	16	17	19	19	22	23	29	29	29	30	30	30	32	32	31	32	35	35	31	31	31	30	29	29	30	31	30	30	29	30	30	34	32
Accounts Payable	1	1	1	2	1	2	2	2	2	2	2	3	3	4	4	3	3	4	4	4	4	4	4	4	3	3	4	4	4	4	4	5	4	3
Long-Term Debt	1	1	1	1	0	2	2	5	5	6	6	5	5	5	5	5	5	8	8	7	8	7	7	7	7	7	7	7	7	6	6	6	7	7
Liabilities	3	3	3	4	3	6	5	8	9	9	9	9	10	11	10	9	10	13	13	13	14	14	13	13	12	12	12	12	13	13	13	15	18	17
Stockholders' Equity		13	14	15	16	17	17	20	20	21	21	21	21	21	22	21	22	22	22	18	17	17	17	17	17	18	19	18	17	16	16	15	15	15


Income Statement ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	6	6	7	6	7	7	7	7	7	7	7	7	7	9	9	9	8	9	8	8	7	10	8	7	9	8	9	8	7	7	10	6	8	8
Cost of Revenue	4	3	4	4	4	4	4	4	4	4	4	5	4	4	4	6	5	5	4	5	5	6	5	5	5	4	5	6	5	5	6	4	4	5
Gross Profit	2	3	3	2	3	3	3	3	3	3	3	3	3	4	4	3	3	3	3	3	3	4	3	3	4	4	4	2	2	2	4	2	4	3
R&D	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A	2	2	2	2	2	2	2	2	3	2	3	3	4	4	3	3	3	3	3	3	3	4	3	3	3	3	3	3	3	3	3	3	3	2
Tax	0	0	0	0	0	0	0	0	0	0	0	0	-1	0	0	0	0	-0	0	3	0	0	0	0	0	0	0	0	0	0	0	-0	-0	-0
Net Income	0																			-4	-1	0	-0	-0	1	1	1	-1	-1	-1	0	-1	-0	0


Cash Flow ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating	1		1	2	0	0	0	1	-0	0	-0	2	-0	1	0	1	-0	0	1	-0	0	1	-0	0	0	1		0	-1	-0		-1
Cash Investing	-0		-1	-1	-1	-3	-0	-4	-1	-0	-1	-0	-1	-1	-1	-1	-1	-2	-1	-0	-0	-0	-0	-0	-0	-0		-0	-0	-0		-0
Cash Financing	-0		0	-0	-0	2	-0	3	-0	0	-0	-0	-0	-0	0	0	0	2	-0	-0	0	-0	-0	-0	-0	-0		-0	1	0		0